Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FY2J5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,677
Award facts
- Contract value 100% obligated
- $12,676.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,676.65 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on November 6, 2025, with completion scheduled for November 7, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The award leverages AmerisourceBergen's position as a critical pharmaceutical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, positioning AmerisourceBergen as a key partner in the DLA's pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DB26FY2J5?
SPE2DB26FY2J5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FY2J5 worth?
The government has obligated $12,677 on SPE2DB26FY2J5.
Is contract SPE2DB26FY2J5 an order under another contract?
Yes. SPE2DB26FY2J5 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY2J5 competed?
The extent of competition for SPE2DB26FY2J5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award